Stockreport

Pinetree Therapeutics Announces Exercise of Option to License EGFR Degrader Program by AstraZeneca [TheStreet.com]

AstraZeneca PLC Ordinary Shares  (AZN) 
Last astrazeneca plc ordinary shares earnings: 2/5 04:00 pm Check Earnings Report
US:NYSE Investor Relations: astrazeneca.com/investor-relations.html
PDF CAMBRIDGE, Mass. April 29, 2026 /PRNewswire/ -- Pinetree Therapeutics, Inc. ("Pinetree"), a biotechnology company pioneering next-generation targeted protein degradatio [Read more]